Vilnius, Lithuania, Oct. 08, 2026 (GLOBE NEWSWIRE) — UAB Esulda, a company managed by the investment company AB Tewox, has successfully completed the construction of a grocery store located at Tunelio St. 4A, Vilnius. The total investment in the project amounts to approximately EUR 6 million. The property is leased on a long-term basis to the supermarket chain Iki, which starts operations in the newly developed premises on 8 October 2026. The total leasable area is approximately 2,100 sq. m. Two additional stores will be built in Lithuania in 2026. In total, more than 10,000 sq. m of leasable area will be developed this year. Contact person for further information: Paulius NevinskasManager of the Investment Companypaulius.nevinskas@lordslb.lthttps://lordslb.lt/tewox_bonds/

INQ Group AB (publ) (“INQ” or the “Company”) today announces that holders of its senior secured convertible loan have elected to convert approximately USD 5.43 million of principal and accrued interest into equity, reducing the principal outstanding under the loan by more than three quarters, from approximately USD 6.7 million to approximately USD 1.55 million. Around 78 per cent of the new shares will be held by the Company’s two largest shareholders and by its directors, management and employees, whom are existing, long-standing investors in INQ. The holders are converting approximately USD 5.15 million of principal, together with approximately USD 0.28 million of accrued interest (USD 5.43 million in total), into 811,913,347 new shares in INQ Group AB at a conversion price of SEK 0.06 per share (at the fixed exchange rate of SEK 9.05...

Revenue and EBITDA margin expectations increased, driven by stronger-than-expected Travel Health salesCOPENHAGEN, Denmark, October 8, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced an upgrade to the financial guidance for the full year 2026, reflecting stronger-than-expected performance in its Travel Health business. Revenue from Travel Health is now expected to reach approximately DKK 3,400 million, compared to previous guidance of approximately DKK 3,000 million. The increase is primarily driven by higher rabies vaccine sales, particularly in the United States, where increased animal rabies activity has led to a significant rise in human exposure and a corresponding increase in demand for both pre- and post-exposure vaccination. All other revenue assumptions remain unchanged from the guidance issued on August 21, 2026. This...

NEW YORK, Oct. 08, 2026 (GLOBE NEWSWIRE) — Reading International, Inc. (NASDAQ: RDI, RDIB) today announced it will hold its 2026 Annual Meeting of Stockholders on Thursday, December 3, 2026, beginning at 2:00 p.m. Eastern Time. The formal portion of the meeting will be followed by a management presentation and a stockholder question and answer session. The Annual Meeting will be held virtually, hosted by Computershare, Inc. The record date for registered stockholders and duly appointed proxyholders entitled to attend the Annual Meeting is October 15, 2026. Registered stockholders who log into the virtual meeting with a control number will be able to listen to the audio webcast, and view presentation materials. Only registered Class B stockholders will be able to communicate, participate in, and vote at the Annual Meeting. Details...

Regulated information – inside informationNazareth-De Pinte (Belgium)/Rotterdam (The Netherlands), 8 October 2026 – 7:00 AM CET Fagron delivers strong 23.2% revenue growth in the third quarter to €281.3 million and confirms FY guidance range Fagron, the leading global player in pharmaceutical compounding, today publishes its quarterly results for the period ending 30 September 2026. Key HighlightsRevenue of €281.3 million, up 23.2% (19.5% at CER1), supported by strong performance in EMEA, Latin America and Brands & Essentials (B&E) in North America–Pacific, together with contribution from acquisitions Organic growth at CER of 3.4%, led by EMEA (6.5%), Latin America (9.7%) and B&E in North America–Pacific (26.1%) Compounding Services in North America–Pacific was impacted by the temporary, industry-wide IV bag recall. The...

Ad Hoc Announcement Pursuant to Art. 53 LR  Geneva, Switzerland, October 8, 2026 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that its spin-out company, Neurosterix, in which Addex holds a 20% equity interest, has completed its Phase 1 clinical studies evaluating NTX-253 and plans to advance NTX-253 into Phase 2 clinical development. NTX-253 is a positive allosteric modulator (PAM) of the muscarinic M4 receptor being developed for the treatment of schizophrenia. “Completing Phase 1 and the decision by Neurosterix to progress NTX-253 into Phase 2 studies in schizophrenia patients is a significant achievement,” said Tim Dyer, CEO of Addex. “The well-designed study...

October 8, 2026, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovation company, today announced that it will discontinue the Phase 3 UNITY study of efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in adults with moderate-to-severe Sjögren’s disease. The decision is based on the recommendation from an Independent Data Monitoring Committee (IDMC) to stop the study for futility following an interim analysis. The IDMC concluded that the UNITY study is unable to meet its primary endpoint. Safety was consistent with efgartigimod’s established profile and no new safety signals were identified. “We are disappointed by this outcome, most of all for people living with Sjögren’s disease, who are still waiting for treatments that fundamentally...

Senior Managing Director Will Co-Lead FTI Consulting’s Aviation Practice in EMEA and Asia, Advising Airlines, Aerospace Companies, Investors and Governments on Capital Raising, Transactions and Transformation DUBAI, United Arab Emirates, Oct. 07, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN), today announced the appointment of Alexis Fekete as a Senior Managing Director in the firm’s Corporate Finance segment. Mr. Fekete will Co-Lead the Aviation practice in Europe, the Middle East, and Africa (“EMEA”) and Asia with Jasper Schrijver. Mr. Fekete, who is based in Dubai, joins FTI Consulting from Seabury Aviation Partners, where he was a Managing Director and Partner. He has also held senior roles at Accenture, Seabury Capital and Natixis, and brings over 20 years of experience across the aviation and aerospace sectors....

MONTREAL, Oct. 07, 2026 (GLOBE NEWSWIRE) — Velan Inc. (TSX: VLN) (“Velan” or the “Company”), a leading global manufacturer of industrial valves, announced today financial results for its second quarter ended August 31, 2026. All amounts are expressed in U.S. dollars unless indicated otherwise. SECOND-QUARTER HIGHLIGHTS FROM CONTINUING OPERATIONS IFRS MEASURESSales of $57.5 million, versus $67.6 million last year, as the timing and complexity of certain production orders shifted shipments into later periods. Uncertainty around changing tariff regulations and ongoing geopolitical tension also weighed on customer demand and order timing during the period. Gross profit of $12.6 million or 21.9%, of sales, compared to $15.7 million, or 23.2% of sales, last year. Net loss1 of $15.1 million ($0.70 per share), versus a net loss of $1.7...

Mining and capital allocation executive with LatAm advisory experience, and senior roles at BHP and Vale joins the Board VANCOUVER, British Columbia, Oct. 07, 2026 (GLOBE NEWSWIRE) — Resouro Strategic Metals Inc. (ASX: RAU; TSX-V: RSM; OTCQB: RSGOF) (“Resouro” or the “Company”) is pleased to announce the appointment of Daniel Kuhl to the Board of directors as an independent, non-executive director effective 7 October, 2026. Mr. Kuhl brings 25 years of international mining and resources experience in capital allocation, strategic planning and M&A, together with familiarity with Resouro from a prior engagement as advisor on the Novo Mundo gold project. Mr. Kuhl most recently served as Senior Advisor and Country Lead for Oliver Wyman in Santiago, Chile, advising mining and industrial executives across Latin America on strategy,...